Registered Trials

• NCT04505722

  Phase 3

  Argentina, Brazil, Chile, Colombia, Mexico, Peru, Philippines, South Africa, Ukraine, United States of America

  Total Enrollment: 44,325

  Official Trial Registration:

  • NCT04505722(Opens in new tab/window)

• NCT04614948, ISRCTN14722499

  Phase 3

  Belgium, Colombia, France, Germany, Philippines, South Africa, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America

  Total Enrollment: 30,000

  Official Trial Registration:

  • NCT04614948(Opens in new tab/window)
  • ISRCTN14722499(Opens in new tab/window)

• NCT04838795

  Phase 3

  South Africa

  Total Enrollment: 500,000

  Official Trial Registration:

  • NCT04838795(Opens in new tab/window)

• NCT04535453, EUCTR2020-002584-63-DE

  Phase 2

  Germany, Netherlands, Spain

  Total Enrollment: 1,210

  Official Trial Registration:

  • NCT04535453(Opens in new tab/window)
  • EUCTR2020-002584-63-DE(Opens in new tab/window)

• NCT04765384

  Phase 2

  South Africa, Spain, United Kingdom of Great Britain and Northern Ireland, United States of America

  Total Enrollment: 400

  Official Trial Registration:

  • NCT04765384(Opens in new tab/window)

• NCT04889209

  Phase 1/2

  United States of America

  Total Enrollment: 400

  Official Trial Registration:

  • NCT04889209(Opens in new tab/window)

• NCT04436276, EUCTR2020-001483-28

  Phase 1/2

  Belgium, United States of America

  Total Enrollment: 1,085

  Official Trial Registration:

  • NCT04436276(Opens in new tab/window)
  • EUCTR2020-001483-28(Opens in new tab/window)

• NCT04509947

  Phase 1

  Japan

  Total Enrollment: 250

  Official Trial Registration:

  • NCT04509947(Opens in new tab/window)

• NCT04894305

  Phase 1

  Netherlands

  Total Enrollment: 380

  Official Trial Registration:

  • NCT04894305(Opens in new tab/window)